ProMIS Neurosciences

ProMIS Neurosciences Inventory

Inventory of ProMIS Neurosciences (PMN) as of Oct 17, 2026.

Inventory

-USD

Last updated:

Inventory of ProMIS Neurosciences is 2026 - USD. Inventory of ProMIS Neurosciences was 2025 - USD. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ProMIS Neurosciences Stock analysis

What does ProMIS Neurosciences do? ProMIS Neurosciences Inc, headquartered in Toronto, Canada, operates in the Health Care sector, specifically within Biotechnology. The company focuses on developing precision medicine solutions for neurodegenerative diseases, targeting toxic misfolded proteins in conditions such as Alzheimer’s, ALS, and multiple system atrophy. It employs six full-time staff and utilizes proprietary computational platforms to discover antibody therapeutics, including PMN310, PMN267, and PMN442, with plans to expand into Parkinson's disease and related disorders. ProMIS Neurosciences is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ProMIS Neurosciences stock

On Eulerpool you can find the complete historical development of Inventory ProMIS Neurosciences since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's ProMIS Neurosciences historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — ProMIS Neurosciences

All Key Metrics — ProMIS Neurosciences